Reason for request
Extension of indication
Clinical Benefit
| Substantial |
Substantial in type 1 diabetes in children aged 2 to 5 years. |
Clinical Added Value
| no clinical added value |
LANTUS provides no improvement in actual benefit (IAB V, non-existent) in the management of children aged 2 to 5 years with type 1 diabetes. |
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
MZxUhhVzv3KDZcFT
Listen
